« Back
Home /
Gemfibrozil

Gemfibrozil

€33.00

Excl. VAT

Item no.	TMO-T1415-25mg
Manufacturer	TargetMol
CASRN	25812-30-0
Amount	25mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Format	Powder
Specific against	other
Purity	0,999
Smiles	Cc1cc(OCCCC(C)(C)C(=O)O)c(C)cc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	25812-30-0, Jezil , CI-719 , Lopid , Decrelip
Available
Short Description	Gemfibrozil interacts with peroxisome proliferator-activated receptors (PPARalpha) resulting in PPARalpha-mediated stimulation of fatty acid oxidation and an increase in lipoprotein lipase (LPL) synthesis. Gemfibrozil is a fibric acid derivative with hypolipidemic effects. This enhances triglyceride-rich lipoprotein clearance and reduces the expression of apolipoprotein C-III (apoC-III). The reduction in hepatic production of apoC-III result in the subsequent reduction of serum levels of very-low-density-lipoprotein cholesterol (VLDL-C). In addition, gemfibrozil-mediated PPARalpha stimulation of apoA-I and apoA-II expression results in an increase in high-density lipoprotein cholesterol (HDL-C).
Shipping	cool pack
Storage	-20°
Target names or alias	Jezil , CI-719 , Lopid , Decrelip
Molecular Weight	250, 33
Pathway	Neuroscience\|\|\|GPCR/G Protein\|\|\|Metabolism\|\|\|DNA Damage/DNA Repair
Target	P450\|\|\|Adrenergic Receptor\|\|\|PPAR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

Listprice: €33.00

Price: €33.00

available

Delivery expected until 8/21/2025

Quantity:

Compare